The 93rd China International Medical Equipment Fair opened in Shanghai on 9 April with AI and surgical robots at the centre of the floor, Vietnam Investment Review reported. Known as CMEF, the fair ran to 12 April at the city’s convention centre. Organisers said it filled more than 320,000 square metres and drew nearly 5,000 brands from over 20 countries and regions. Vietnam Investment Review, a Vietnamese business paper, put expected turnout above 200,000 buyers and visitors, a figure it gave as the organisers did, and vendor counts of this kind read as claims rather than audited attendance.
AI and robots on the floor
Much of the floor went to the “AI plus healthcare” category, Vietnam Investment Review reported. Organisers showed the global debut of an AI agent built for “one scan, multiple diagnoses”, which they said could spot conditions across several parts of the body from a single scan. That claim of many diagnoses from one scan is a sales line until independent results confirm it, and the paper reported none. A separate AI tool was already in clinical use, it said, and a training platform was shown to raise the power of hospitals that install it. Device makers also brought surgical, rehabilitation and elderly-care robots, part of the automation push on show at Hong Kong’s robotic surgery hub.
For the first time, the fair set aside a Future Tech Arena for three fields organisers expect to shape later products. It covered brain-computer interfaces, embodied intelligence and university research, and displayed AI-assisted MRI systems for Alzheimer’s disease, brain-computer interface systems for cognitive assessment, and exoskeleton robots. Organisers presented these as prototypes and early clinical tools rather than settled treatments. That framing matters for anyone weighing where to seek care, because a prototype on a trade floor is a long way from a procedure a foreign patient can book.
Trade, not patients
CMEF is a trade fair for device makers, and its international side was built around exporters rather than patients. Vietnam Investment Review reported that the International Zone drew firms from more than 20 countries and regions, among them Germany, the United States, Japan, France and Malaysia. Organisers ran a “We” series of matchmaking events, the WeTalk Stage, the WeMatch Hub and the International WeTour, to pair buyers with suppliers, the paper said. Matchmaking is the point of a fair this size. With turnout expected above 200,000, the WeMatch Hub existed to turn a crowd into signed supply deals, and organisers also worked with the units of several hospitals to handle care for visiting delegates.
CMEF’s clearest medical tourism signal sat in its regulatory sessions. The Global Harmonization Working Party and Malaysia’s health ministry co-hosted the GHWP’s third device seminar and an ASEAN forum on medical device rules, the paper said, both aimed at aligning when a device may cross a border. Harmonised rules would let a scanner cleared in one market sell into another without a second full review, the kind of friction that slows the spread of new equipment. That effort runs alongside a wider regional push, from Singapore’s device regulator reaching the WHO’s top tier to China’s own opening to foreign hospital operators.
An announcement, not an outcome
A device fair is an announcement of capability, not proof that patients will follow. Equipment shown in Shanghai reaches medical tourism only once it is installed in accredited hospitals and shown to change what happens to patients, and neither step is settled on a trade floor. The scan agent was a debut, the exoskeletons were prototypes, and the forums were talks about rules rather than the rules themselves. China’s pitch as a healthcare destination rests on the test that faces every host, whether the tools bought here end up treating foreign patients at named hospitals, a bet visible in Guangzhou’s medical tourism service centre.
What to watch
The dated items are near. CMEF ran from 9 to 12 April, and its regulatory track leaves two checkable threads. One is whether the working party and Malaysia’s health ministry turn their two seminars into a common device standard. The other is whether the scan agent moves from its Shanghai debut into clinical use at hospitals that treat international patients.